{"article":{"annotation":{"article_id":"goa-life-course-immunization-policy-research-2026","available_at":"2026-10-07T03:14:17.442701Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"3bf47d2bf044d6745c33738c6fd7ca4600b087100afeb0ff59242002d85e92f3","input_sha256":"93bd2b33d5048868ea2a3a8259b6982e522aecb8c5eb43eadffdee114bdb3e36","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"IN","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://ahpsr.who.int/newsroom/news/item/02-10-2026-research-at-the-policy-table-how-goa-built-india-s-first-dedicated-life-course-immunization-policy","https://www.goa.gov.in/wp-content/uploads/2026/09/646.pdf"]}],"geometry":null,"id":"iso3166-1:IN","kind":"country-or-area","labels":{"ar":"الهند","en":"India","es":"India","fr":"Inde"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"d28c9c89703b56bd91fd887965d416d0115c2473d4bfbd3e558bcceafc3941dd","schema_version":1,"subjects":[{"concept_id":"medtop:20000448","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: influenza","source_urls":["https://ahpsr.who.int/newsroom/news/item/02-10-2026-research-at-the-policy-table-how-goa-built-india-s-first-dedicated-life-course-immunization-policy","https://www.goa.gov.in/wp-content/uploads/2026/09/646.pdf"]}],"method":"controlled-rules-v1","rule_id":"communicable-disease","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=en","category":"health","content":{"key_points":[],"paragraphs":["On 23 September, the Indian state of Goa said it had become the country’s first state to adopt a dedicated life-course immunisation policy. The 2026–2036 framework aims to bring adult vaccination into routine healthcare beyond childhood. In a report published on 2 October, the World Health Organization’s Alliance for Health Policy and Systems Research said the first implementation phase would offer influenza, pneumococcal and hepatitis B vaccines to eligible adults, including people with chronic diseases, immunocompromised patients and health workers.","The Alliance described a research process in which the Goa government worked with researchers from the Goa Institute of Management and Oxford Policy Management (India) to weigh clinical risk and existing health-system capacity. The state’s launch release also lists the same three vaccine types for the initial phase and says delivery will be integrated into existing services. The sources describe a rollout plan; they do not yet report vaccine doses delivered, participation, coverage or real-world effectiveness."],"sections":[]},"corrections":[{"at":"2026-10-07T00:49:30+03:00","language":"en","text":"German and Portuguese editions and translations of the data and correction explanations have been added to this article."},{"at":"2026-10-07T05:57:45+03:00","language":"en","text":"Data classification corrected: measure identifiers and types now follow the dataset rules. No figure, unit or date changed."}],"country":"IN","data":{"blocks":[{"description":{"ar":"أنواع اللقاحات المدرجة للمرحلة التنفيذية الأولى من إطار السياسة 2026–2036 الذي أُعلن في 23 سبتمبر 2026.","de":"Impfstoffarten für die erste Umsetzungsphase des am 23. September 2026 angekündigten politischen Rahmens für 2026–2036.","en":"Vaccine types listed for the initial implementation phase of the 2026–2036 policy framework announced on 23 September 2026.","es":"Tipos de vacunas enumerados para la fase inicial de aplicación del marco político 2026–2036 anunciado el 23 de septiembre de 2026.","fr":"Types de vaccins indiqués pour la première phase de mise en œuvre du cadre politique 2026–2036 annoncé le 23 septembre 2026.","pt":"Tipos de vacina listados para a fase inicial de implementação da política de 2026–2036 anunciada em 23 de setembro de 2026.","tr":"23 Eylül 2026'da açıklanan 2026–2036 politika çerçevesinin ilk uygulama aşamasında kaynakların sıraladığı aşı türleri."},"id":"goa-first-phase-vaccine-types","items":[{"basis":"target","label":{"ar":"أنواع اللقاحات المدرجة للتنفيذ الأولي: الإنفلونزا والمكورات الرئوية والتهاب الكبد B","de":"Für die erste Umsetzung vorgesehene Impfstoffe: Influenza, Pneumokokken und Hepatitis B","en":"Vaccine types listed for initial implementation: influenza, pneumococcal and hepatitis B","es":"Tipos de vacunas indicados para la aplicación inicial: gripe, neumococo y hepatitis B","fr":"Types de vaccins inscrits pour la mise en œuvre initiale : grippe, pneumocoque et hépatite B","pt":"Tipos de vacina previstos para a implementação inicial: influenza, pneumococo e hepatite B","tr":"İlk uygulama aşamasında listelenen aşı türü sayısı: grip, pnömokok ve hepatit B"},"measure":{"aggregation":"stock","frequency":"irregular","geography":"goa-india","id":"goa-initial-adult-immunisation-vaccine-types","periodRole":"announcement-date","unitCode":"count"},"period":"2026-09-23","unit":"count","value":3}],"methodology":{"ar":"يحصي هذا المؤشر أنواع اللقاحات المختلفة المذكورة للمرحلة الأولى في السياسة والإرشادات التشغيلية؛ ولا يمثل عدد الجرعات أو كمية الشراء أو عدد الأشخاص المطعّمين أو التغطية المحققة. وتشمل الفئات ذات الأولوية البالغين المؤهلين وفق نهج قائم على المخاطر، ومنهم المصابون بأمراض مزمنة وضعيفو المناعة والعاملون الصحيون.","de":"Gezählt werden die unterschiedlichen Impfstoffarten, die in Politik und operativer Anleitung für die erste Phase genannt werden; es handelt sich nicht um Dosen, Beschaffungsmengen, Zahl geimpfter Personen oder erreichte Abdeckung. Vorranggruppen sind nach Risiko ausgewählte Erwachsene, darunter Menschen mit chronischen Erkrankungen, immungeschwächte Patientinnen und Patienten sowie Beschäftigte im Gesundheitswesen.","en":"This counts the distinct vaccine types named for the initial phase in the policy and operational guidance; it is not a dose count, procurement volume, number of vaccinated people or achieved coverage. Priority groups are eligible adults selected by risk, including people with chronic disease, immunocompromised patients and health workers.","es":"Este indicador cuenta los tipos de vacunas distintos incluidos para la fase inicial en la política y las directrices operativas; no es un recuento de dosis, volumen de compra, personas vacunadas ni cobertura alcanzada. Los grupos prioritarios son adultos elegibles seleccionados según el riesgo, incluidas personas con enfermedades crónicas, inmunodeprimidas y trabajadores de la salud.","fr":"Cet indicateur compte les types de vaccins distincts mentionnés pour la phase initiale dans la politique et les directives opérationnelles ; il ne s’agit ni d’un nombre de doses, ni d’un volume d’achat, ni d’un nombre de personnes vaccinées, ni d’une couverture atteinte. Les groupes prioritaires sont les adultes admissibles sélectionnés selon le risque, notamment les personnes atteintes de maladies chroniques, immunodéprimées et les professionnels de santé.","pt":"Contam-se os tipos distintos de vacina mencionados na política e nas orientações operacionais para a fase inicial; não se trata de doses, volumes de aquisição, número de pessoas vacinadas nem cobertura alcançada. Os grupos prioritários são adultos selecionados por risco, incluindo pessoas com doenças crônicas, pacientes imunocomprometidos e profissionais de saúde.","tr":"Bu gösterge, politika ve operasyonel yönergede ilk aşama için sayılan farklı aşı türlerinin adedidir; doz, doz sayısı, satın alma miktarı, aşılanan kişi veya gerçekleşmiş kapsam değildir. Öncelikli hedef gruplar, kronik hastalığı olanlar, bağışıklığı baskılanmış kişiler ve sağlık çalışanları dahil risk temelli uygun yetişkinlerdir."},"sourceUrls":["https://ahpsr.who.int/newsroom/news/item/02-10-2026-research-at-the-policy-table-how-goa-built-india-s-first-dedicated-life-course-immunization-policy","https://www.goa.gov.in/wp-content/uploads/2026/09/646.pdf"],"title":{"ar":"المرحلة الأولى من سياسة غوا للتطعيم مدى الحياة","de":"Erste Phase von Goas Impfpolitik für den gesamten Lebensverlauf","en":"First phase of Goa’s life-course immunisation policy","es":"Primera fase de la política de inmunización a lo largo de la vida de Goa","fr":"Première phase de la politique de vaccination tout au long de la vie de Goa","pt":"Fase inicial da política de imunização de Goa ao longo da vida","tr":"Goa'nın yaşam boyu bağışıklama politikasının ilk aşaması"},"type":"metrics","updatedAt":"2026-10-07T00:49:30+03:00"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026/data/goa-first-phase-vaccine-types?lang=en&format=csv","json":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026/data/goa-first-phase-vaccine-types?lang=en&format=json"},"id":"goa-first-phase-vaccine-types"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Conceptual illustration of public health, research and connected data.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-b17a4029-9014-5d63-af92-af3101b5e10a","event_period":"2026-09-23","event_period_basis":"event-or-reference-period","id":"goa-life-course-immunization-policy-research-2026","image":null,"importance":0.6,"language":"en","modified_at":"2026-10-07T05:57:45+03:00","publication_basis":"publication-record","published_at":"2026-10-04T14:04:24+00:00","reading_minutes":2,"region":"world","section_illustration":{"alt":"Conceptual illustration of public health, research and connected data.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"en","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"goa-life-course-immunization-policy-research-2026","sources":[{"checkedAt":"2026-10-04","name":"WHO Alliance for Health Policy and Systems Research","publishedAt":"2026-10-02","url":"https://ahpsr.who.int/newsroom/news/item/02-10-2026-research-at-the-policy-table-how-goa-built-india-s-first-dedicated-life-course-immunization-policy"},{"checkedAt":"2026-10-04","name":"Department of Information & Publicity, Government of Goa","publishedAt":"2026-09-23","url":"https://www.goa.gov.in/wp-content/uploads/2026/09/646.pdf"}],"summary":"Goa has launched a life-course immunisation policy for 2026–2036. Its initial phase will offer influenza, pneumococcal and hepatitis B vaccines to at-risk adult groups.","text":"Goa has launched a life-course immunisation policy for 2026–2036. Its initial phase will offer influenza, pneumococcal and hepatitis B vaccines to at-risk adult groups.\n\nOn 23 September, the Indian state of Goa said it had become the country’s first state to adopt a dedicated life-course immunisation policy. The 2026–2036 framework aims to bring adult vaccination into routine healthcare beyond childhood. In a report published on 2 October, the World Health Organization’s Alliance for Health Policy and Systems Research said the first implementation phase would offer influenza, pneumococcal and hepatitis B vaccines to eligible adults, including people with chronic diseases, immunocompromised patients and health workers.\n\nThe Alliance described a research process in which the Goa government worked with researchers from the Goa Institute of Management and Oxford Policy Management (India) to weigh clinical risk and existing health-system capacity. The state’s launch release also lists the same three vaccine types for the initial phase and says delivery will be integrated into existing services. The sources describe a rollout plan; they do not yet report vaccine doses delivered, participation, coverage or real-world effectiveness.\n\nGerman and Portuguese editions and translations of the data and correction explanations have been added to this article.\n\nData classification corrected: measure identifiers and types now follow the dataset rules. No figure, unit or date changed.","title":"Goa brings adult vaccination into a life-course policy","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/goa-life-course-immunization-policy-research-2026"},{"api_url":"https://newsverum.com/api/v1/articles/goa-life-course-immunization-policy-research-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/goa-life-course-immunization-policy-research-2026"}],"url":"https://newsverum.com/en/news/goa-life-course-immunization-policy-research-2026"},"version":"1"}